IMFINZI
As listed in the register: IMFINZI 50 mg/ml, solution à diluer pour perfusion
50 mg · solution à diluer pour perfusion
- Prescription only
- Active substance
- Durvalumab
- Made by
- ASTRAZENECA AB
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
Spain6 matching products
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | ASTRAZENECA AB |
|---|---|
| Active substance | Durvalumab |
| Strength | 50 mg |
| Form | solution à diluer pour perfusion |
| Route | intraveineuse |
| Dispensing (as stated by the register) | réservé à l'usage HOSPITALIER · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · liste I · prescription réservée aux médecins compétents en CANCEROLOGIE |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/18/1322 |
| Name in the register | IMFINZI 50 mg/ml, solution à diluer pour perfusion |
| Packs | 1 flacon en verre de 10 ml · 1 flacon en verre de 2,4 ml |
| CIS | 63690956 |
| CIP13 | 3400955058144 |
| CIP13 | 3400955058151 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).